KHAN NAJAT (CEO and President) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/19/2026ACC: 0001601830-26-000019
DirectorOfficer· CEO and President
Since Feb 2026
-14.28K
Net shares
Net seller
$49.8K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
14.28K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−14.28K
Price / share
$3.49
Trade value
$49.84K
% of position
0.6%
2/17/2026
2.30M→2.29M
Total
Net shares
−14.28K
Net value
-$49.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/17/2026 | F · Tax Withholding | −14.28K | $3.49 | $49.84K | 0.6% | 2.30M | 2.29M |
| Total | −14.28K | -$49.84K | ||||||
Derivative Transactions0
No derivative transactions reported